Dear Stakeholder,
These are challenging times. To me, there is no doubt that humankind will triumph. In doing so, it will show its resiliency, fortitude, and kindness in each of us.
As a diagnostic provider, we are currently working with the US federal agencies and our global partner companies to see how our capabilities and expertise may...
Read more
About: DMI
Recent Posts by DMI
DMI and COVID-19
rHEALTH Technology Granted US Patent for Small Volume Blood Handling in Point-of-Care Devices
Invention enables manipulation of small blood samples for accurate point-of-care diagnosis
BEDFORD, Mass., January 5, 2020 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., announced today the issuance of United States Patent Number 10,449,537 titled “Capillary manipulation of clinical samples.” The patent describes a system for collection and delivery of minute blood samples to...
Read more
rHEALTH FVIII Solution to be Presented at WFH’s 11th Global Forum
“We are very pleased to be invited by WFH to present our FVIII solution for home and in-office measurement of FVIII levels. Our approach provides a high-level of accuracy for FVIII measurements, particularly for long-acting and gene therapy-based FVIII therapies where conventional testing via activated partial thromboplastin time is less appropriate,” said Eugene Y. Chan,...
Read more
rHEALTH ONE Blood Analyzers Delivered to NASA for International Space Station
Blood analyzers to be qualified for spaceflight by NASA’s Commercial-Off-The Shelf (COTS) certification process
CAMBRIDGE, Mass., September 30, 2019 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., today announced that rHEALTH ONE blood analyzers have been delivered to NASA and its prime contractor Zin Technologies for spaceflight qualification. The technology will undergo a rigorous...
Read more
Abstracts for rHEALTH’s Factor VIII and Platelet Tests Accepted for Poster and Oral Presentations at Upcoming AACC 2019 Meeting
rHEALTH tests to be presented at the industry’s leading annual conference for laboratory medicine
CAMBRIDGE, Mass., July 11, 2019 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., today announced that both of its abstracts have been accepted via peer-review from for the 2019 American Association of Clinical Chemistry (AACC) meeting. The titles and details...
Read more
Recent Comments by DMI
No comments by DMI yet.
